NHS national Generic Pharmaceuticals Transition 2021_2
A Contract Award Notice
by THE NHS COMMISSIONING BOARD (OPERATING UNDER THE NAME OF NHS ENGLAND)
- Source
- Find a Tender
- Type
- Framework (Goods)
- Duration
- not specified
- Value
- £1
- Sector
- HEALTH
- Published
- 04 Jun 2021
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
United Kingdom: Please refer to document 03, schedule 8 in the ITO documents for the list of Purchasing Points
1 buyer
17 suppliers
- Milpharm Middlesex
- Thornton & Ross Huddersfield
- Day Lewis Medical Surrey
- Waverley Pharma Europe The Sweepstakes
- Bristol Laboratories Hertfordshire
- Amarox Middlesex
- Drreddys Laboratories East Yorkshire
- Lexon East Redditch
- Aspire Pharma Hampshire
- Brown & Burk Middlesex
- Morningside Pharmaeuticals Loughborough
- Cipla Eu London
- Ranbaxy Hayes
- Selective Supplies West Sussex
- Laboratorio Reig Jofre Devon
- Accord Devon
- Neon Healthcare Herts
Description
Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: Allregions: 15/06/2021 to 28/02/2022 (8.5months)Transition CESW: 15/06/2021 to30/06/2022 (12.5 months)LSNE: 15/06/2021 to 31/01/2023 (19.5months)NWLN: 15/06/2021 to 31/01/2022 (7.5months)Hospital Only Housekeeping Products:All regions: 15/06/2021 to 31/01/2022 (7.5 months)
Lot Division
| 1 | CM/PHG/20/5631/00 Transition Products - CESW Region NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number:Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 15/06/2021 to 28/02/2022 (8.5 months)Transition CESW: 15/06/2021 to 30/06/2022 (12.5 months)LSNE: 15/06/2021 to 31/01/2023 (19.5 months)NWLN: 15/06/2021 to 31/01/2022 (7.5 months)Hospital Only Housekeeping Products: All regions: 15/06/2021 to 31/01/2022 (7.5 months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents |
| 2 | CM/PHG/20/5631/00 Transition Products - LSNE Region NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number:Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 15/06/2021 to 28/02/2022 (8.5 months)Transition CESW: 15/06/2021 to 30/06/2022 (12.5 months)LSNE: 15/06/2021 to 31/01/2023 (19.5 months)NWLN: 15/06/2021 to 31/01/2022 (7.5 months)Hospital Only Housekeeping Products: All regions: 15/06/2021 to 31/01/2022 (7.5 months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents |
| 3 | CM/PHG/20/5631/00 Transition Products - NWLN Region NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number:Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 15/06/2021 to 28/02/2022 (8.5 months)Transition CESW: 15/06/2021 to 30/06/2022 (12.5 months)LSNE: 15/06/2021 to 31/01/2023 (19.5 months)NWLN: 15/06/2021 to 31/01/2022 (7.5 months)Hospital Only Housekeeping Products: All regions: 15/06/2021 to 31/01/2022 (7.5 months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents |
| 4 | CM/PHG/20/5631/01 - Oral (plus non-parenteral) Products - All Regions NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number:Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 15/06/2021 to 28/02/2022 (8.5 months)Transition CESW: 15/06/2021 to 30/06/2022 (12.5 months)LSNE: 15/06/2021 to 31/01/2023 (19.5 months)NWLN: 15/06/2021 to 31/01/2022 (7.5 months)Hospital Only Housekeeping Products: All regions: 15/06/2021 to 31/01/2022 (7.5 months) Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents |
| 5 | CM/PHG/20/5631/02 - Hospital Only/Housekeeping - DLS/DNE/DNW Regions NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number:Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 15/06/2021 to 28/02/2022 (8.5 months)Transition CESW: 15/06/2021 to 30/06/2022 (12.5 months)LSNE: 15/06/2021 to 31/01/2023 (19.5 months)NWLN: 15/06/2021 to 31/01/2022 (7.5 months)Hospital Only Housekeeping Products: All regions: 15/06/2021 to 31/01/2022 (7.5 months) Hide Section - II.2.5) Award CriteriaII.2.5) Award Criteria. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents |
| 6 | CM/PHG/20/5631/02 - Hospital Only/Housekeeping - DLN/DCE/DSW Regions NHS National Pharmaceuticals Transition 2021_2Offer reference number: CM/PHG/20/5631Period of framework agreement: The total maximum duration of the framework agreement to be no more than 39 months (19.5 months plus options to extend (at the Authority's sole discretion) for up to a further 19.5 months)OJEU Reference number:Potential periods of call-offs under the framework agreement:Oral (plus non-parenteral) Products: All regions: 15/06/2021 to 28/02/2022 (8.5 months)Transition CESW: 15/06/2021 to 30/06/2022 (12.5 months)LSNE: 15/06/2021 to 31/01/2023 (19.5 months)NWLN: 15/06/2021 to 31/01/2022 (7.5 months)Hospital Only Housekeeping Products: All regions: 15/06/2021 to 31/01/2022 (7.5 months) Hide Section - II.2.5) Award CriteriaII.2.5) Award Criteria. Additional information: Price is not the only award criterion and all criteria are stated only in the procurement documents |
Award Detail
| 1 | Milpharm (Middlesex)
|
| 2 | Thornton & Ross (Huddersfield)
|
| 3 | Day Lewis Medical (Surrey)
|
| 4 | Waverley Pharma Europe (The Sweepstakes)
|
| 5 | Bristol Laboratories (Hertfordshire)
|
| 6 | Amarox (Middlesex)
|
| 7 | Drreddys Laboratories (East Yorkshire)
|
| 8 | Lexon (East Redditch)
|
| 9 | Aspire Pharma (Hampshire)
|
| 10 | Brown & Burk (Middlesex)
|
| 11 | Morningside Pharmaeuticals (Loughborough)
|
| 12 | Cipla Eu (London)
|
| 13 | Ranbaxy (Hayes)
|
| 14 | Selective Supplies (West Sussex)
|
| 15 | Laboratorio Reig Jofre (Devon)
|
| 16 | Accord (Devon)
|
| 17 | Neon Healthcare (Herts)
|
| 18 | Milpharm (Middlesex)
|
| 19 | Thornton & Ross (Huddersfield)
|
| 20 | Day Lewis Medical (Surrey)
|
| 21 | Waverley Pharma Europe (The Sweepstakes)
|
| 22 | Bristol Laboratories (Hertfordshire)
|
| 23 | Amarox (Middlesex)
|
| 24 | Drreddys Laboratories (East Yorkshire)
|
| 25 | Lexon (East Redditch)
|
| 26 | Aspire Pharma (Hampshire)
|
| 27 | Brown & Burk (Middlesex)
|
| 28 | Morningside Pharmaeuticals (Loughborough)
|
| 29 | Cipla Eu (London)
|
| 30 | Ranbaxy (Hayes)
|
| 31 | Selective Supplies (West Sussex)
|
| 32 | Laboratorio Reig Jofre (Devon)
|
| 33 | Accord (Devon)
|
| 34 | Neon Healthcare (Herts)
|
| 35 | Milpharm (Middlesex)
|
| 36 | Thornton & Ross (Huddersfield)
|
| 37 | Day Lewis Medical (Surrey)
|
| 38 | Waverley Pharma Europe (The Sweepstakes)
|
| 39 | Bristol Laboratories (Hertfordshire)
|
| 40 | Amarox (Middlesex)
|
| 41 | Drreddys Laboratories (East Yorkshire)
|
| 42 | Lexon (East Redditch)
|
| 43 | Aspire Pharma (Hampshire)
|
| 44 | Brown & Burk (Middlesex)
|
| 45 | Morningside Pharmaeuticals (Loughborough)
|
| 46 | Cipla Eu (London)
|
| 47 | Ranbaxy (Hayes)
|
| 48 | Selective Supplies (West Sussex)
|
| 49 | Laboratorio Reig Jofre (Devon)
|
| 50 | Accord (Devon)
|
| 51 | Neon Healthcare (Herts)
|
| 52 | Milpharm (Middlesex)
|
| 53 | Thornton & Ross (Huddersfield)
|
| 54 | Day Lewis Medical (Surrey)
|
| 55 | Waverley Pharma Europe (The Sweepstakes)
|
| 56 | Bristol Laboratories (Hertfordshire)
|
| 57 | Amarox (Middlesex)
|
| 58 | Drreddys Laboratories (East Yorkshire)
|
| 59 | Lexon (East Redditch)
|
| 60 | Aspire Pharma (Hampshire)
|
| 61 | Brown & Burk (Middlesex)
|
| 62 | Morningside Pharmaeuticals (Loughborough)
|
| 63 | Cipla Eu (London)
|
| 64 | Ranbaxy (Hayes)
|
| 65 | Selective Supplies (West Sussex)
|
| 66 | Laboratorio Reig Jofre (Devon)
|
| 67 | Accord (Devon)
|
| 68 | Neon Healthcare (Herts)
|
| 69 | Milpharm (Middlesex)
|
| 70 | Thornton & Ross (Huddersfield)
|
| 71 | Day Lewis Medical (Surrey)
|
| 72 | Waverley Pharma Europe (The Sweepstakes)
|
| 73 | Bristol Laboratories (Hertfordshire)
|
| 74 | Amarox (Middlesex)
|
| 75 | Drreddys Laboratories (East Yorkshire)
|
| 76 | Lexon (East Redditch)
|
| 77 | Aspire Pharma (Hampshire)
|
| 78 | Brown & Burk (Middlesex)
|
| 79 | Morningside Pharmaeuticals (Loughborough)
|
| 80 | Cipla Eu (London)
|
| 81 | Ranbaxy (Hayes)
|
| 82 | Selective Supplies (West Sussex)
|
| 83 | Laboratorio Reig Jofre (Devon)
|
| 84 | Accord (Devon)
|
| 85 | Neon Healthcare (Herts)
|
| 86 | Milpharm (Middlesex)
|
| 87 | Thornton & Ross (Huddersfield)
|
| 88 | Day Lewis Medical (Surrey)
|
| 89 | Waverley Pharma Europe (The Sweepstakes)
|
| 90 | Bristol Laboratories (Hertfordshire)
|
| 91 | Amarox (Middlesex)
|
| 92 | Drreddys Laboratories (East Yorkshire)
|
| 93 | Lexon (East Redditch)
|
| 94 | Aspire Pharma (Hampshire)
|
| 95 | Brown & Burk (Middlesex)
|
| 96 | Morningside Pharmaeuticals (Loughborough)
|
| 97 | Cipla Eu (London)
|
| 98 | Ranbaxy (Hayes)
|
| 99 | Selective Supplies (West Sussex)
|
| 100 | Laboratorio Reig Jofre (Devon)
|
| 101 | Accord (Devon)
|
| 102 | Neon Healthcare (Herts)
|
Award Criteria
| price | _ |
CPV Codes
- 33600000 - Pharmaceutical products
- 33690000 - Various medicinal products
Indicators
- Options are available.
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. ** RESPONDING TO THIS NOTICE;Any supplier may be disqualified who does not respond to the following in the requisite manner:1) Submission of expression of interest and procurement specific information. This procurement exercise will be conducted on the eTendering portal at http://health.atamis.co.ukCandidates wishing to be considered for this procurement exercise must register, and provide additional procurement specific information (if requested) through thee Tendering portal as follows:1.1) If not already registered, Candidates should register on the eTendering portal at http://health.atamis.co.uk and click the link to register:- agree to the user agreement- populate company details1.2) Once registered, candidates must register interest as follows:- log to the portal- select "Find Opportunities" from the supplier home screen, use the "Sort by:" facility to find this opportunity and select the bold blue title to select- review opportunity details and click "Register Interest"- as you select the opportunity, you can review documents, send clarification messages,submit the response or decline to respond (if you decide not to participate in the opportunity)1.3) There is a supplier user guide on using the system and Candidates can contact the Atamis helpdesk at supporthealth@atamis.co.uk or by calling 0800 9956035 for technical assistance when completing responses.2) General supplier information.To manage and assess supplier information the Contracting Authority requests candidates provide theircompany profile in the Government's Supplier Registration Service (which has replaced (sid4gov), as follows:2.1) If not already registered (the previous sid4gov password, login and details will stillbe on the system), candidates must go to the following web page https://supplierregistration.cabinetoffice.gov.ukand select "Register" at the top of the page.Key in details as requested to search for your company. If you do not have a D-U-N-S®Number, click on the link at the right of the page to obtain a number from D&B.Candidates must obtain a Dun & Bradstreet(D&B) D-U-N-S® Number to enable registration on the system.2.2) Once registration is complete you are able to create and update your company profile. Candidates should ensure all the mandatory fields of their profile are completed and up to date for each procurement exercise.D&B data will be supplied automatically by D&B.2.3) For further help or information concerning this telephone +44 (0) 161 413 7982 or via themessage function on the website.OTHER CONTRACTING AUTHORITIESThe framework agreement is for the benefit of other participating NHS bodies (whether acting individually, or on behalf of, or together as members of any consortia) along with any other non-NHS bodies which the participants deem necessary for the delivery of services or goods to NHS bodies, local authorities, other government departments or non-departmental public bodies charged with the delivery of healthcare or health related services.
Reference
- ocds-h6vhtk-028bae
- FTS 012546-2021